Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: Experimental models and clinical perspectives

Cell Cycle

Volumn 8, Issue 7, 2009, Pages 970-976

  Ahn, G One ^a   Brown, J Martin ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basement membrane; Bone marrow derived cells; Myeloid cells; Pericyte; Radiation; Solid tumors; Tumor vasculature

Indexed keywords

ANTINEOPLASTIC AGENT; CD31 ANTIGEN; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; GELATINASE B; GELATINASE B INHIBITOR; GELATINASE INHIBITOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

BONE MARROW CELL; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL FUNCTION; DRUG INHIBITION; HEMATOPOIETIC CELL; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MUCOSA INFLAMMATION; NEUTROPENIA; NONHUMAN; PERICYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION DOSE; REVIEW; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 65949123145     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.7.8075     Document Type: Review

References (69)

1. Verellen D, De Ridder M, Linthout N, Tournel K, Soete G, Storme G. Innovations in image-guided radiotherapy. Nat Rev Cancer 2007; 7:949-960 (Pubitemid 350165868)
2. Chao KSC, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Rad Oncol Biol Phys 2003; 55:312-321 (Pubitemid 36069088)
3. Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Rad Oncol Biol Phys 2004; 59:28-42.
4. Chao KSC, Ozyigit G, Blanco AI, Thorstad WL, Deasy JO, Haughey BH, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Rad Oncol Biol Phys 2004; 59:43-50.
5. Brown WT, Wu X, Fayad F, Fowler JF, Amendola BE, García S, et al. CyberKnife radiosurgery for stage I lung cancer: results at 36 months. Clin Lung Cancer 2007; 8:488-492
6. Shinohara ET, Geng L, Tan J, Chen H, Shir Y, Edwards E, et al. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Res 2005; 65:4987-4992 (Pubitemid 40827302)
7. Banáth JP, MacPhail SH, Olive PL. Radiation sensitivity, H2AX phosphorylation and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res 2004; 64:7144-7149 (Pubitemid 39331029)
8. Zeng M, Narayanan L, Xu XS, Prolla TA, Liskay M, Glazer PM. Ionizing radiation-induced apoptosis via separate pms2- and p53-dependent pathways. Cancer Res 2000; 60:4889-4893
9. Brown JM, Wilson W. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004; 4:437-447 (Pubitemid 38745529)
10. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-364 (Pubitemid 26272076)
11. Ahn GO, Brown JM. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 2008; 13:193-205.
12. Gerweck LE, Vijayappa S, Kurimasa A, Ogawa K, Chen DJ. Tumor cell radiosensitivity is a major determinant of tumor response to radiation. Cancer Res 2006; 66:8352-8385 (Pubitemid 44449143)
13. Ogawa K, Boucher Y, Kashiwagi S, Fukumura D, Chen D, Gerweck LE. Influence of tumor cell and stroma sensitivity on tumor response to radiation. Cancer Res 2007; 67:4016-4021 (Pubitemid 46815045)
14. Liang K, Ang KK, Milas L, Hunter N, Fan Z. The epidermal growth factor receptor mediates radioresistance. Int J Rad Oncol Biol Phys 2003; 57:246-254 (Pubitemid 36959763)
15. Chinnaiyan P, Huang S, Vallabhaneni G, Armstrong E, Varambally S, Tomlins SA, et al. Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva). Cancer Res 2005; 65:3328-3335 (Pubitemid 40524617)
16. Gow C-H, Chien C-R, Chang Y-L, Chiu Y-H, Kuo S-H, Shih J-Y, et al. Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response. Clin Cancer Res 2008; 14:162-168
17. Baumann M, Krause M. Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiother Oncol 2004; 72:257-266 (Pubitemid 39265378)
18. Burdelya LG, Komarova EA, Hill JE, Browder T, Tararova ND, Mavrakis L, et al. Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice. Cancer Res 2006; 66:9356-9361
19. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003; 300:1155-1159
20. Budach W, Hartford A, Gioioso D, Freeman J, Taghian A, Suit HD. Tumors arising in SCID mice share enhanced radiation sensitivity of SCID normal tissues. Cancer Res 1992; 52:6292-6296
21. Budach W, Taghian A, Freeman J, Gioioso D, Suit HD. Impact of stromal sensitivity on radiation response of tumors. J Natl Cancer Inst 1993; 85:988-993 (Pubitemid 23177585)
22. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002; 2:826-835
23. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, Gupta S, et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007; 21:1546-1558
24. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells repsonsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85:221-228
25. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7:1194-1201
26. Schlaeger TM, Qin Y, Fujiwara Y, Magram J, Sato TN. Vascular endothelial cell lineagespecific promoter in transgenic mice. Development 1995; 121:1089-1098
27. Motoike T, Loughna S, Perens E, Roman BL, Liao W, Chau TC, et al. Universal GFP reporter for the study of vascular development. Genesis 2000; 28:75-81.
28. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA 2008; 105:6620-6625
29. De Palma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 2003; 9:789-795 (Pubitemid 36749231)
30. Gothert JR, Gustin SE, van Eekelen AM, Schmidt U, Hall MA, Jane SM, et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 2004; 104:1769-1777
31. Bagley RG, Walter-Yohrling J, Cao X, Weber W, Simons B, Cook BP, et al. Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells. Cancer Res 2003; 63:5866-5873
32. + cells in tumor-beaing host directly promotes tumor angiogenesis. Cancer Cell 2004; 6:409-421
33. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66:605-612 (Pubitemid 43165918)
34. Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, Schanz S, et al. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat Biotech 2007; 25:911-920
35. Milas L, Hunter N, Peters LJ. The tumor bed effect: dependence of tumor take, growth rate and metastasis on the time interval between irradiation and tumor cell transplantation. Int J Rad Oncol Biol Phys 1987; 13:379-383 (Pubitemid 17053951)
36. Milas L, Hunter N, Peters LJ. Tumor bed effect-induced reduction of tumor radiocurability through the increase in hypoxic cell fraction. Int J Rad Oncol Biol Phys 1989; 16:139-142 (Pubitemid 19045346)
37. Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K. The tumor bed effect: increased dissemination from hypoxia-induced upregulation of metastasis-promiting gene products. Cancer Res 2005; 65:2387-2396 (Pubitemid 40490150)
38. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, et al. HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008; 13:206-220
39. Giraudo E, Inoue M, Hanahan D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 2004; 114:623-633 (Pubitemid 39578752)
40. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contribute to skin carcinogenesis. Cell 2000; 103:481-490
41. Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 2006; 103:12493-12498 (Pubitemid 44267286)
42. Rabbany SY, Heissig B, Hattori K, Rafii S. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol Med 2003; 9:109-117 (Pubitemid 36433892)
43. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, et al. VEGF-induced adult neovascularization: recruitment, retention and role of accessory cells. Cell 2006; 124:175-189
44. Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment. Nat Med 2002; 8:841-849
45. Varney ML, Olsen KJ, Mosley RL, Singh RK. Paracrine regulation of vascular endothelial growth factor-α expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor. J Interferon Cytokine Res 2005; 25:674-683 (Pubitemid 43010522)
46. Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, et al. Regulation of HIF-1α stability through S-nitrosylation. Mol Cell 2007; 26:63-74.
47. Gianelli U, Vener C, Raviele PR, Savi F, Somalvico F, Calori R, et al. VEGF expression correlates with microvessel densitity in Philadelphia chromosome-negative chronic myeloproliferative disorders. Am J Clin Pathol 2007; 128:966-973
48. + myeloid cells that promote metastasis. Cancer Cell 2008; 13:23-35.
49. Milas L. Tumor bed effect in murine tumors: relationship to tumor take and tumor macrophage content. Radiat Res 1990; 123:232-236 (Pubitemid 20262306)
50. Milas L, Ito H, Hunter N, Jones S, Peters LJ. Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type. Cancer Res 1986; 46:723-727 (Pubitemid 16145429)
51. Baumann M, Wurschmidt F, Twardy A, Beck-Bornholdt H-P. Impact of tumor stroma on expression of the tumor bed effect in R1H rat rhabdomyosarcoma. Radiat Res 1994; 140:432-436 (Pubitemid 24381493)
52. Ershler WB, Moore AL, Shore H, Gamelli RL. Transfer of age-associated restrained tumor growth in mice by old-to-young bone marrow transplantation. Cancer Res 1984; 44:5677-5680 (Pubitemid 15183577)
53. Udagawa T, Birsner AE, Wood M, D'Amato RJ. Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconsistution. Cancer Res 2007; 67:2040-2045 (Pubitemid 46424221)
54. Tsai JH, Makonnen S, Feldman M, Sehgal CM, Maity A, Lee WMF. Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis. Cancer Biol Ther 2005; 4:1395-1400 (Pubitemid 43131187)
55. Abdollahi A, Lipson KE, Han X, Krempien R, Trinh T, Weber KJ, et al. SU5416 and SU6668 attenuates the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. Cancer Res 2003; 63:3755-3763
56. Itasaka S, Komaki R, Herbst RS, Shibuya K, Shintani T, Hunter NR, et al. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Rad Oncol Biol Phys 2007; 67:870-878
57. Zips D, Eicheler W, Geyer P, Hessel F, Dorfler A, Thames HD, et al. Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition. Cancer Res 2005; 65:5374-5379
58. Kozin SV, Winkler F, Garkavtsev I, Hicklin DJ, Jain RK, Boucher Y. Human tumor xenografts recurring after radiotherapy are more sensitive to anti-vascular endothelial growth factor receptor-2 treatment than treatment-naive tumors. Cancer Res 2007; 67:5076-5082 (Pubitemid 46997241)
59. Mancuso MR, Davis R, Norberg SM, O'Brien S, Sennino B, Nakahara T, et al. Rapid vascular regrowth in tumors after reversal of VEGF inhibition. J Clin Invest 2006; 116:2610-2621
60. Kobayashi M. The irradiation effects on the cytoskeletons of C3H/He mouse mammary tumor cells and vascular basement membrane in relation to vascular invasion: a model of intraoperative radiotherapy. Tohoku J Exp Med 1988; 154:71-89. (Pubitemid 18100905)
61. Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, Opolon P, et al. Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Mol Cancer Ther 2005; 4:1717-1728
62. McNally LR, Rosenthal EL, Zhang W, Buchsbaum DJ. Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation. Cancer Gene Ther 2008; 16:246-255
63. Patni N, Patni S, Bapna A. The optimal use of granulocyte macrophage colony stimulating factor in radiation induced mucositis in head and neck squamous cell carcinoma. J Cancer Res Ther 2005; 1:136-141
64. Kuzhan O, Ozet A, Ulutin C, Komurcu S, Arpaci F, Ozturk B, et al. Survival benefit with GM-CSF use after high-dose chemotherapy in high-risk breast cancer. Tumori 2007; 93:550-556
65. Shojaei F, Zhong C, Wu X, Yu L, Ferrara N. Role of myeloid cells in tumor angiogenesis and growth. Trends Cell Biol 2008; 18:372-378
66. Di Maio M, Gridelli C, Gallo C, Shepherd F, Piantedosi FV, Cigolari S, et al. Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials. Lancet Oncol 2005; 6:669-677
67. Okamoto R, Ueno M, Yamada Y, Takahashi N, Sano H, Suda T, et al. Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood 2005; 105:2757-2763
68. Aicher A, Rentsch M, Sasaki K, Ellwart JW, Fandrich F, Siebert R, et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 2007; 100:581-589
69. Bertolini F. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells. Cancer Metastasis Rev 2008; 27:95-101.